In a different approach, Ferrando and colleagues [11] have demonstrated the predictive value of molecular signatures linked to oncogene expression (TLX1, TAL1, LYL1, LMO1, and LMO2) in T-ALL. This evidence concerns the gene LMO1 and acute lymphoblastic leukemia.